We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
55 hedge funds and large institutions have $9.44M invested in Madrigal Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 22 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,800% more call options, than puts
Call options by funds: $19K | Put options by funds: $1K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $9.88M → $9.44M (-$439K)
19% less funds holding
Funds holding: 68 → 55 (-13)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
55% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 22
Holders
55
Holders Change
-13
Holders Change %
-19.12%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
10
Reduced
22
Closed
23
Calls
$19K
Puts
$1K
Net Calls
+$18K
Net Calls Change
-$2K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$693K |
| 2 |
AC
Armistice Capital
New York
|
+$206K |
| 3 |
Millennium Management
New York
|
+$168K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$84.1K |
| 5 |
AGM
Alpine Global Management
New York
|
+$66.2K |
